Skip to main content

Table 1 Characteristics of 130 ESCC patients with local primary-recurrence at initial treatment

From: Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT

Variable

Total (%)

(n = 130)

Re-RT

(n = 30)

Chemotherapy

(n = 29)

Esophageal stent (n = 8)

Other treatment

(n = 5)

Without treatment

(n = 58)

Gender

      

Male

96(73.8)

24(18.5)

22(16.9)

5(3.8)

5(3.8)

40(30.8)

Female

34(26.2)

6(4.6)

7(5.4)

3(2.3)

0(0.0)

18(13.8)

Age

      

≤ 65

57(43.8)

13(10.0)

14(10.8)

3(2.3)

4(3.1)

23(17.7)

> 65

73(56.2)

17(13.1)

15(11.5)

5(3.8)

1(0.8)

35(26.9)

PS

      

0/1

82(63.1)

24(18.5)

18(13.8)

5(3.8)

3(2.3)

32(24.6)

2

48(36.9)

6(4.6)

11(8.5)

3(2.3)

2(1.5)

26(20.0)

T stage

      

1/2

19(14.6)

7(5.4)

1(0.8)

0(0.0)

0(0.0)

11(8.5)

3/4

111(85.4)

23(17.7)

28(21.5)

8(6.2)

5(3.8)

47(36.2)

N stage

      

0/1

107(82.3)

28(21.5)

23(17.7)

7(5.4)

4(3.1)

45(34.6)

2/3

23(17.7)

2(1.5)

6(4.6)

1(0.8)

1(0.8)

13(10.0)

Clinical stage

      

I/II

34(26.2)

9(6.9)

7(5.4)

3(2.3)

0(0.0)

15(11.5)

III/IV

96(73.8)

21(16.2)

22(16.9)

5(3.8)

5(3.8)

43(33.1)

Tumor location

      

Upper and middle thoracic

80(61.5)

17(13.1)

19(14.6)

5(3.8)

4(3.1)

35(26.9)

Lower thoracic

50(38.5)

13(10.0)

11(8.5)

3(2.3)

1(0.8)

23(17.7)

Tumor length(cm)

      

≤ 5

66(50.8)

18(13.8)

12(9.2)

5(3.8)

2(1.5)

29(22.3)

> 5

64(49.2)

12(9.2)

17(13.1)

3(2.3)

3(2.3)

29(22.3)

Radiotherapy technique

      

IMRT

51(39.2)

21(16.2)

7(5.4)

3(2.3)

0(0.0)

20(15.4)

VMAT

79(60.8)

9(6.9)

22(16.9)

5(3.8)

5(3.8)

38(29.2)

Initial radiation dose (Gy)

      

≤ 60

75(57.7)

13(10.0)

20(15.4)

4(3.1)

3(2.3)

35(26.9)

> 60

55(42.3)

17(13.1)

9(6.9)

4(3.1)

2(1.5)

23(17.7)

Concurrent chemotherapy

      

Yes

92(70.8)

22(16.9)

22(16.9)

4(3.1)

5(3.8)

39(30.0)

No

38(29.2)

8(6.2)

7(5.4)

4(3.1)

0(0.0)

19(14.6)

RFI (months)

      

≤ 12

80(61.5)

9(6.9)

19(14.6)

6(4.6)

2(1.5)

44(33.8)

> 12

50(38.5)

21(16.2)

10(7.7)

2(1.5)

3(2.3)

14(10.8)